Substance active (DCI)
- facteur Willebrand humain + facteur VIII de coagulation humain
Informations techniques
Exploitant
français du Fractionnement et des Biotechnologies
Présentation
WILSTART, poudres et solvants pour solution injectable
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
HE4z46N7rZANmwft
Écouter
Français